Clinical problem-solving. High time for action. Kallianpur AR, Poehling KA, Dittus RS (2001) N Engl J Med 344: 48-51 Factor XI antisense oligonucleotide for prevention of venous thrombosis. Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI, FXI-ASO TKA Investigators (2015) N Engl J Med 372: 232-40 A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJ, Renné T, Gruber A, Gailani D (2010) Blood 116: 3981-9 Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor. Despotis GJ, Hogue CW, Santoro SA, Joist JH, Barnes PW, Lappas DG (1995) Crit Care Med 23: 1674-9 Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A (2012) Intensive Care Med 38: 1326-35 On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, Lappas DG (1994) Anesthesiology 80: 338-51 Monitoring activity of fibrinolytic agents. A therapeutic challenge. Shafer KE, Santoro SA, Sobel BE, Jaffe AS (1984) Am J Med 76: 879-86 Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Bock PE, Srinivasan KR, Shore JD (1981) Biochemistry 20: 7258-66 In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Despotis GJ, Summerfield AL, Joist JH, Goodnough LT, Santoro SA, Zimmermann JJ, Lappas DG (1994) Anesth Analg 79: 670-4 Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Chaturvedi S, Cockrell E, Espinola R, Hsi L, Fulton S, Khan M, Li L, Fonseca F, Kundu S, McCrae KR (2015) Thromb Res 135: 102-8 A murine model of factor XI deficiency. Gailani D, Lasky NM, Broze GJ (1997) Blood Coagul Fibrinolysis 8: 134-44
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.